Search papers, labs, and topics across Lattice.
This cross-sectional study investigated the prevalence, at-risk groups, and access to care for movement disorders (MDs) in Cabo Verde, finding an age-standardized MD prevalence of 17 per 100,000, with Parkinson's Disease (PD) accounting for 79% of cases. The study of 110 adults with confirmed MDs identified significant challenges in accessing medication, with 70% reporting moderate to severe difficulties. These findings highlight the need for improved early diagnosis and decentralized services.
High rates of medication access barriers in Cabo Verde suggest that even when pharmacotherapy is available for movement disorders, a large proportion of patients face significant challenges in obtaining it.
Movement disorders (MDs), including Parkinson’s disease (PD) and essential tremor, are growing causes of disability globally. Yet, data on MDs in low- and middle-income countries (LMICs), including Cabo Verde, remain scarce. This study aimed to estimate MD prevalence and incidence, identify at-risk groups, and evaluate access to care. A multi-site, country-level cross-sectional study was conducted from July to December 2024, including 110 adults with confirmed MDs. Data were obtained via clinical record reviews, interviews, and a structured questionnaire. Analyses included descriptive statistics, multivariable logistic regression, and thematic analysis of open-text responses. The age-standardized MD prevalence was 17 per 100,000 population (95% CI: 13–20), with higher rates in men [19 (14–25)] and in those over 60 [117 (89–145)]. PD accounted for 79% of cases. While 78% used pharmacotherapy, 70% faced moderate or severe difficulties accessing medication, and 35% of those who sought therapy reported facing barriers. Fifty-one percent experienced a significant life impact. Findings reveal significant access challenges and rising MD burden, underscoring the need for early diagnosis, decentralized services, and public health system strengthening in LMICs.
